Search icone
Search and publish your papers

Indian pharmaceutical industry

Or download with : a doc exchange

About the author


About the document

Published date
documents in English
market study
9 pages
3 times
Validated by
0 Comment
Rate this document
  1. Introduction
  2. Top 10 pharmaceutical company
  3. The process patent regime
  4. Porter's five force analysis
  5. SWOT analysis
  6. Advantage in India
  7. Trends in the Indian pharmaceutical industry
  8. Impact of the union budget 2008-09
  9. PEST analysis
  10. Future outlook
  11. Conclusion
  12. Bibliography

The Indian Pharmaceuticals sector has come a long way, being almost non-existent during 1970, to a prominent provider of health care products, meeting almost 95% of country's pharmaceutical needs. London research company Global Insight estimates that India's share of the global generics market will have risen from 4% to 33% by 2007. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Indian market. India's US$ 3.1 billion pharmaceutical industry is growing at the rate of 14 percent per year. It is one of the largest and most advanced among the developing countries. The Indian Pharmaceutical Industry today is in the front rank of India's science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured.

[...] Also in developing countries like India, the traditional medicines also play a major substituting role INTENSITY OF RIVALRY: the Indian Pharmaceutical industry is highly fragmented with around 250-300 manufacturing & formulation units in the organized sector which contribute to only 70% of the market share of the total sales in the country. The concentration ratio (proportion of total industry output by the largest firm in the industry) for the industry is very low. Also government subsidies have led to the proliferation of many small players. [...]

[...] FEW TOP COMPANIES RANBAXY India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. The Company is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharmaceuticals markets of the world. The Company with a global footprint in 49 countries, world-class manufacturing facilities in 11 and a diverse product portfolio, is rapidly moving towards global leadership, riding on its success in the world's emerging and developed markets. [...]

[...] There exists a significant export potential for the Indian companies being one of the lowest cost producers. FDA approved plants will act as an advantage for them. With the aging of the world population combined with new diagnoses & new social diseases, the demand for medical products on a whole is increasing. Also, there is a growing attention to health. Moreover, with new therapy approaches & new delivery systems, Indian industry is bound to grow. There is a huge potential for the development of India as a centre for international clinical trials. [...]

Similar documents you may be interested in reading.

A comparative study of the market potential of different cardiovascular drugs in the...

 Science & technology   |  Medical studies   |  Indian project   |  05/09/2009   |   .doc   |   56 pages

Impact of FDI on the industrial development in India

 Economics & finance   |  Economics   |  Research papers   |  05/21/2009   |   .doc   |   39 pages

Top sold for business strategy

Nike's outsourcing strategy

 Business & market   |  Business strategy   |  Case study   |  01/27/2011   |   .doc   |   5 pages

HRM in companies: Ryanair, IBM, Google, IKEA

 Business & market   |  Business strategy   |  Case study   |  03/06/2014   |   .doc   |   12 pages